Loading…
Whitehawk Therapeutics, Inc. is projected to rise to $4.39 by 2027, a +14% move from its current price of $3.85. WHWK is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $3.75 | $3.85 | $3.95 | +0.03% |
| Aug 4 | $3.71 | $3.85 | $4.00 | +0.06% |
| Aug 5 | $3.68 | $3.85 | $4.03 | +0.09% |
| Aug 6 | $3.66 | $3.85 | $4.06 | +0.12% |
| Aug 7 | $3.63 | $3.86 | $4.09 | +0.15% |
| Aug 8 | $3.61 | $3.86 | $4.12 | +0.17% |
| Aug 9 | $3.60 | $3.86 | $4.14 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.60 | $3.86 | $4.14 | +0.20% |
| Week 2 | $3.50 | $3.87 | $4.27 | +0.41% |
| Week 3 | $3.43 | $3.87 | $4.37 | +0.61% |
| Week 4 | $3.37 | $3.88 | $4.47 | +0.82% |
| Week 5 | $3.32 | $3.89 | $4.55 | +1.02% |
| Week 6 | $3.28 | $3.90 | $4.63 | +1.23% |
| Week 7 | $3.24 | $3.91 | $4.70 | +1.44% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Whitehawk Therapeutics, Inc. is a clinical-stage oncology therapeutics company focused on technologies that establish tumor biology to guide cancer treatments. It maintains a portfolio of three next-generation antibody drug conjugates (ADC) designed to treat cancer.
The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021.
Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Whitehawk Therapeutics, Inc. trades at $3.71 per share and has a market capitalization of $183.47M. It is ranked 3642.
The current price sits near the 50-day SMA of $4.23 and above the 200-day SMA of $3.27.
Forecast data show upside potential with a path from 2026 avg $3.71 to 2030 avg $6.65 and 2050 avg $30.94. Implied ROIs rise to 79.3% by 2030 and 733.9% by 2050, with bullish sentiment in later years.
The near-term outlook remains subject to market dynamics and company-specific developments.
A major floor 19.2% below — a decisive break under it would weaken the trend.
The nearest floor, 4.9% below — buyers have tended to step in here.
The nearest ceiling, 19.0% above — a clean break opens room to run.
A major ceiling 32.5% above — clearing it would confirm fresh momentum.
Key WHWK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WHWK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.75 | Buy | $3.79 | Buy |
| MA 10 | $3.80 | Buy | $3.81 | Buy |
| MA 20 | $3.86 | Sell | $3.88 | Sell |
| MA 50 | $4.14 | Sell | $4.00 | Sell |
| MA 100 | $4.03 | Sell | $3.86 | Sell |
| MA 200 | $3.31 | Buy | $3.46 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.64 | Neutral |
| Stoch RSI (14) | 86.97 | Sell |
| CCI (20) | -7.81 | Neutral |
| Williams %R (14) | -42.42 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 57.58 | Neutral |
| TRIX (15) | -0.42 | Sell |
| Awesome (5,34) | -0.29 | Sell |
| Ultimate (7,14,28) | 41.01 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 3.75 | Buy |
| ADX (14) | 13.12 | Neutral |
| ATR (14) | 0.09 | Info |
The 30-day range is $3.07 to $4.48, and the current price sits at the stated support of $3.71.
The RSI14 is 40, with the 50-day simple moving average at $4.23 and the 200-day simple moving average at $3.27.
A near-term resistance is at $4.58.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.44 | $3.85 | $4.96 | 0% | Neutral | |
| $3.51 | $4.39 | $5.79 | +14% | Neutral | |
| $3.78 | $4.85 | $6.65 | +26% | Bullish | |
| $4.96 | $6.52 | $9.19 | +69% | Bullish | |
| $5.51 | $7.38 | $10.66 | +92% | Bullish | |
| $5.73 | $7.83 | $11.54 | +103% | Bullish | |
| $6.58 | $9.14 | $13.73 | +137% | Bullish | |
| $6.47 | $9.13 | $13.95 | +137% | Bullish | |
| $6.60 | $9.45 | $14.66 | +145% | Bullish | |
| $7.62 | $11.06 | $17.42 | +187% | Bullish | |
| $11.12 | $17.22 | $28.81 | +347% | Bullish | |
| $21.77 | $37.67 | $68.86 | +879% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.44 | $3.85 | $4.79 | +0.00% |
| September 2026 | $3.44 | $4.07 | $4.94 | +5.64% |
| October 2026 | $3.32 | $3.95 | $4.85 | -2.79% |
| November 2026 | $3.27 | $3.91 | $4.84 | -1.15% |
| December 2026 | $3.31 | $3.98 | $4.96 | +1.81% |
Click any year to see its month-by-month WHWK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, WHWK is projected to trade between $2.44 and $4.96, averaging $3.85 — a potential gain of 0% from today's $3.85. Price action looks broadly range-bound.
Whitehawk Therapeutics, Inc.'s 2027 outlook centres on $4.39, within a $3.51 to $5.79 range. That is up +14% on the projected 2026 average. That marks a +14% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, WHWK could reach as high as $6.65, with a base case around $4.85 and support toward $3.78 — roughly +26% from $3.85. Momentum favours further upside here.
Expect WHWK to range from $4.96 to $9.19 through 2029. The $6.52 average target implies a +69% move from current prices. That is up +34% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The WHWK price prediction for 2030 points to an average of $7.38 (low $5.51, high $10.66) — a potential gain of +92% on today's $3.85. Momentum favours further upside here.
In 2031, WHWK is projected to trade between $5.73 and $11.54, averaging $7.83 — a potential gain of +103% from today's $3.85. That is up +6% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Whitehawk Therapeutics, Inc.'s 2032 outlook centres on $9.14, within a $6.58 to $13.73 range. That is up +17% on the projected 2031 average. That marks a +137% change versus current levels. Momentum favours further upside here.
By 2033, WHWK could reach as high as $13.95, with a base case around $9.13 and support toward $6.47 — roughly +137% from $3.85. Buyers look set to stay in control over this stretch.
Expect WHWK to range from $6.60 to $14.66 through 2034. The $9.45 average target implies a +145% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The WHWK price prediction for 2035 points to an average of $11.06 (low $7.62, high $17.42) — a potential gain of +187% on today's $3.85. Buyers look set to stay in control over this stretch.
In 2040, WHWK is projected to trade between $11.12 and $28.81, averaging $17.22 — a potential gain of +347% from today's $3.85. That is up +56% on the projected 2035 average. Momentum favours further upside here.
Whitehawk Therapeutics, Inc.'s 2050 outlook centres on $37.67, within a $21.77 to $68.86 range. That is up +119% on the projected 2040 average. That marks a +879% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in WHWK today (≈ 259.74026 WHWK) could be worth
$9,785.1
+$8,785.1 (+879%) by 2050 · US Dollar
Based on the average projected WHWK price of $37.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WHWKwould be worth at today's price.
$1,000 invested in WHWK on Jul 31, 2025 (≈ 571.428571 WHWK) would be worth
$2,200
+$1,200 (+120.0%) today · 2.20× · US Dollar
Based on a WHWK entry price of $1.75 vs. today's $3.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.71 | $1,037.74 | +3.8% |
| 1 month ago | $4.3 | $895.35 | -10.5% |
| 3 months ago | $3.99 | $964.91 | -3.5% |
| 6 months ago | $2.88 | $1,336.81 | +33.7% |
| 1 year ago | $1.75 | $2,200 | +120.0% |
| All time (5.0y) ago | $30.3 | $127.06 | -87.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WHWK forecast.
Our base-case forecast reaches $7.70 around 2031.
Implied market cap at $7.70: $380.78M
Over the multi-year horizon, the forecast shows an upside trajectory. The sequence starts with 2026 avg $3.71, then 2027 avg $4.08, 2028 avg $4.48, 2029 avg $5.96, and 2030 avg $6.65.
By 2040 the avg forecast is $14.67 and by 2050 the avg is $30.94. ROI climbs to 295.4% in 2040 and 733.9% in 2050, with sentiment bullish across the longer horizon.
These are estimates; volatility is high at 50% annualized, and actual results may differ.
Tap a question to reveal the answer.
Avg $6.65; min $4.89; max $9.77; ROI 79.3%; sentiment BULLISH.
Forecasts show upside through the horizon, with 2031 avg $7.07, 2032 avg $8.19, 2040 avg $14.67, and 2050 avg $30.94. ROI rises to 90.5% by 2031, 120.7% by 2032, 295.4% by 2040, and 733.9% by 2050. These are estimates, not guarantees.
Yes. The forecast allows a max of $12.54 in 2032 and a max of $10.61 in 2031, meaning $12 could be reached within the forecast horizon.
Current price $3.71; market cap $183.47M.
Avg $14.67; min $9.20; max $25.17; ROI 295.4%; sentiment BULLISH.
Whitehawk Therapeutics, Inc. Community Discussion
0Share your Whitehawk Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.